FOSL1 is an AP-1 transcription factor that has prognostic value in human solid tumors such as breast cancer, lung cancer, pancreatic cancer, and colon cancer, and its overexpression is associated with tumor progression or reduced patient survival rates [64, 65]. Here, FOSL1 is linked to breast carcinoma.